Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Redox-Responsive Disulfide Bond-Bridged mPEG-PBLA Prodrug Micelles for Enhanced Paclitaxel Biosafety and Antitumor Efficacy.

Chang S, Wang Y, Zhang T, Pu X, Zong L, Zhu H, Zhao L, Feng B.

Front Oncol. 2019 Aug 27;9:823. doi: 10.3389/fonc.2019.00823. eCollection 2019.

2.

Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.

Yin T, Wu Q, Wang L, Yin L, Zhou J, Huo M.

Mol Pharm. 2015 Aug 3;12(8):3020-31. doi: 10.1021/acs.molpharmaceut.5b00280. Epub 2015 Jun 30.

PMID:
26086430
3.

Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.

Lv S, Tang Z, Zhang D, Song W, Li M, Lin J, Liu H, Chen X.

J Control Release. 2014 Nov 28;194:220-7. doi: 10.1016/j.jconrel.2014.09.009. Epub 2014 Sep 16.

PMID:
25220162
4.

Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance.

Dong K, Yan Y, Wang P, Shi X, Zhang L, Wang K, Xing J, Dong Y.

Int J Nanomedicine. 2016 Oct 6;11:5109-5123. eCollection 2016.

5.

Redox-sensitive mPEG-SS-PTX/TPGS mixed micelles: An efficient drug delivery system for overcoming multidrug resistance.

Zhao D, Zhang H, Yang S, He W, Luan Y.

Int J Pharm. 2016 Dec 30;515(1-2):281-292. doi: 10.1016/j.ijpharm.2016.10.029. Epub 2016 Oct 13.

PMID:
27746331
6.

pH-sensitive and folic acid-targeted MPEG-PHIS/FA-PEG-VE mixed micelles for the delivery of PTX-VE and their antitumor activity.

Di Y, Li T, Zhu Z, Chen F, Jia L, Liu W, Gai X, Wang Y, Pan W, Yang X.

Int J Nanomedicine. 2017 Aug 16;12:5863-5877. doi: 10.2147/IJN.S141982. eCollection 2017.

7.

Acetal-Linked Paclitaxel Polymeric Prodrug Based on Functionalized mPEG-PCL Diblock Polymer for pH-Triggered Drug Delivery.

Zhai Y, Zhou X, Jia L, Ma C, Song R, Deng Y, Hu X, Sun W.

Polymers (Basel). 2017 Dec 11;9(12). pii: E698. doi: 10.3390/polym9120698.

8.

Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel.

Zhang X, Wu Y, Zhang M, Mao J, Wu Y, Zhang Y, Yao J, Xu C, Guo W, Yu B.

Int J Nanomedicine. 2017 Dec 13;12:8779-8799. doi: 10.2147/IJN.S150196. eCollection 2017.

9.

Engineering folate-targeting diselenide-containing triblock copolymer as a redox-responsive shell-sheddable micelle for antitumor therapy in vivo.

Behroozi F, Abdkhodaie MJ, Abandansari HS, Satarian L, Molazem M, Al-Jamal KT, Baharvand H.

Acta Biomater. 2018 Aug;76:239-256. doi: 10.1016/j.actbio.2018.05.031. Epub 2018 Jun 19.

PMID:
29928995
10.

Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.

Yin S, Huai J, Chen X, Yang Y, Zhang X, Gan Y, Wang G, Gu X, Li J.

Acta Biomater. 2015 Oct;26:274-85. doi: 10.1016/j.actbio.2015.08.029. Epub 2015 Aug 20.

PMID:
26300335
11.

Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel.

Li J, Yin T, Wang L, Yin L, Zhou J, Huo M.

Int J Pharm. 2015 Apr 10;483(1-2):38-48. doi: 10.1016/j.ijpharm.2015.02.002. Epub 2015 Feb 2.

PMID:
25655715
12.

Multifunctional Hyaluronic Acid-Decorated Redox-Responsive Magnetic Complex Micelle for Targeted Drug Delivery with Enhanced Antitumor Efficiency and Anti-Cell-Migration Activity.

Sang M, Zhang Z, Liu F, Hu L, Li L, Chen L, Feng F, Liu W, Qu W.

J Biomed Nanotechnol. 2018 Mar 1;14(3):477-495. doi: 10.1166/jbn.2018.2541.

PMID:
29663921
13.

Disulfide-Linked Amphiphilic Polymer-Docetaxel Conjugates Assembled Redox-Sensitive Micelles for Efficient Antitumor Drug Delivery.

Zhang P, Zhang H, He W, Zhao D, Song A, Luan Y.

Biomacromolecules. 2016 May 9;17(5):1621-32. doi: 10.1021/acs.biomac.5b01758. Epub 2016 Apr 5.

PMID:
27018501
14.

Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.

Jiang C, Wang H, Zhang X, Sun Z, Wang F, Cheng J, Xie H, Yu B, Zhou L.

Int J Pharm. 2014 Nov 20;475(1-2):60-8. doi: 10.1016/j.ijpharm.2014.08.037. Epub 2014 Aug 23.

PMID:
25152167
15.

Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.

Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W.

J Control Release. 2010 Apr 2;143(1):136-42. doi: 10.1016/j.jconrel.2009.12.020. Epub 2010 Jan 7.

PMID:
20056123
16.

Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.

Song Y, Cai H, Yin T, Huo M, Ma P, Zhou J, Lai W.

Int J Nanomedicine. 2018 Mar 15;13:1585-1600. doi: 10.2147/IJN.S155383. eCollection 2018.

17.

Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery.

Li Y, Xiao K, Luo J, Xiao W, Lee JS, Gonik AM, Kato J, Dong TA, Lam KS.

Biomaterials. 2011 Sep;32(27):6633-45. doi: 10.1016/j.biomaterials.2011.05.050. Epub 2011 Jun 11.

18.

Redox-sensitive micelles assembled from amphiphilic mPEG-PCL-SS-DTX conjugates for the delivery of docetaxel.

Zhang H, Wang K, Zhang P, He W, Song A, Luan Y.

Colloids Surf B Biointerfaces. 2016 Jun 1;142:89-97. doi: 10.1016/j.colsurfb.2016.02.045. Epub 2016 Feb 23.

PMID:
26938324
19.

Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.

Zhang J, Zhao X, Chen Q, Yin X, Xin X, Li K, Qiao M, Hu H, Chen D, Zhao X.

Acta Biomater. 2017 Mar 1;50:381-395. doi: 10.1016/j.actbio.2016.12.021. Epub 2016 Dec 9.

PMID:
27956367
20.

Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.

Chuan X, Song Q, Lin J, Chen X, Zhang H, Dai W, He B, Wang X, Zhang Q.

Mol Pharm. 2014 Oct 6;11(10):3656-70. doi: 10.1021/mp500399j. Epub 2014 Sep 24.

PMID:
25208098

Supplemental Content

Support Center